381 results on '"Dahia, Patricia"'
Search Results
2. TMEM127 suppresses tumor development by promoting RET ubiquitination, positioning, and degradation
3. A membrane-associated MHC-I inhibitory axis for cancer immune evasion
4. Author response: Loss of tumor suppressor TMEM127 drives RET-mediated transformation through disrupted membrane dynamics
5. Single-nuclei and bulk-tissue gene-expression analysis of pheochromocytoma and paraganglioma links disease subtypes with tumor microenvironment
6. International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriers
7. Loss of tumor suppressor TMEM127 drives RET-mediated transformation through disrupted membrane dynamics.
8. MYC Regulation of D2HGDH and L2HGDH Influences the Epigenome and Epitranscriptome
9. IRF8-mutant B cell lymphoma evades immunity through a CD74-dependent deregulation of antigen processing and presentation in MHC CII complexes
10. Loss of Tumour Suppressor TMEM127 Drives RET-mediated Transformation Through Disrupted Membrane Dynamics
11. A Previously Unrecognized Monocytic Component of Pheochromocytoma and Paraganglioma
12. A membrane-associated inhibitory axis of MHC-I presentation for cancer immune evasion
13. Abstract A10: Targeting MHC-I antigen presentation for cancer immune evasion in acute myeloid leukemia
14. Abstract 195: Establishment and validation of pheochromocytoma organoids for high-throughput drug screening
15. Supplementary Figure 1 from A Novel Germline Mutation in BAP1 Predisposes to Familial Clear-Cell Renal Cell Carcinoma
16. Supplementary Methods from A Novel Germline Mutation in BAP1 Predisposes to Familial Clear-Cell Renal Cell Carcinoma
17. Supplementary Figure 2 from A Novel Germline Mutation in BAP1 Predisposes to Familial Clear-Cell Renal Cell Carcinoma
18. Supplementary Figure Legend from A Novel Germline Mutation in BAP1 Predisposes to Familial Clear-Cell Renal Cell Carcinoma
19. Data from A Novel Germline Mutation in BAP1 Predisposes to Familial Clear-Cell Renal Cell Carcinoma
20. The tumor suppressor TMEM127 regulates insulin sensitivity in a tissue-specific manner
21. A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas.
22. Supplemental Figures 1-6 from Recurrent Mutations of Chromatin-Remodeling Genes and Kinase Receptors in Pheochromocytomas and Paragangliomas
23. Supplemental Tables 1-5 from Recurrent Mutations of Chromatin-Remodeling Genes and Kinase Receptors in Pheochromocytomas and Paragangliomas
24. Supplementary Figures 1 - 3 from MAX Mutations Cause Hereditary and Sporadic Pheochromocytoma and Paraganglioma
25. Supplementary Appendix List and Supplemental Methods from Recurrent Mutations of Chromatin-Remodeling Genes and Kinase Receptors in Pheochromocytomas and Paragangliomas
26. Supplementary Data and Table 1 from Novel Pheochromocytoma Susceptibility Loci Identified by Integrative Genomics
27. Update on the genetics of paragangliomas
28. Recognizing hypoxia in phaeochromocytomas and paragangliomas
29. Case report: Two sisters with a germline CHEK2 variant and distinct endocrine neoplasias
30. Hypoxia-Inducible Factor 2 Alpha (HIF2α) Inhibitors: Targeting Genetically Driven Tumor Hypoxia
31. A RET::GRB2 fusion in pheochromocytoma defies the classic paradigm of RET oncogenic fusions
32. Molecular Biology of Pheochromocytomas and Paragangliomas
33. Hypoxia-Inducible Factor 2 Alpha (HIF2α) Inhibitors: Targeting Genetically Driven Tumor Hypoxia.
34. Consensus on molecular imaging and theranostics in neuroendocrine neoplasms
35. Thyroid nodules of indeterminate cytology in Hispanic/Latinx patients
36. Abstract #1180161: Sympathetic Paraganglioma associated with X-linked hypophosphatemia: ¿Is there a genetic link?
37. Endocrine and Neuroendocrine Tumors Special Issue—Checkpoint Inhibitors for Adrenocortical Carcinoma and Metastatic Pheochromocytoma and Paraganglioma: Do They Work?
38. A Novel RET-GRB2 Fusion in Pheochromocytoma Defies the Classic Paradigm of RET Oncogenic Fusions
39. Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations
40. Targeting of SMAD5 Links microRNA-155 to the TGF-β Pathway and Lymphomagenesis
41. Role of SDHAF2 and SDHD in von Hippel–Lindau Associated Pheochromocytomas
42. VHL Disease
43. Insights into Mechanisms of Pheochromocytomas and Paragangliomas Driven by Known or New Genetic Drivers
44. International initiative for a curated SDHB variant database improving the diagnosis of hereditary paraganglioma and pheochromocytoma
45. Penetrance and Clinical Features of Pheochromocytoma in a Six-Generation Family Carrying a Germline TMEM127 Mutation
46. International initiative for a curated SDHB variant database improving the diagnosis of hereditary paraganglioma and pheochromocytoma.
47. The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Management of Metastatic and/or Unresectable Pheochromocytoma and Paraganglioma
48. Coordinated expression of microRNA-155 and predicted target genes in diffuse large B-cell lymphoma
49. Spectrum and prevalence of FP/TMEM127 gene mutations in pheochromocytomas and paragangliomas
50. Targeting of SMAD5 links microRNA-155 to the TGF-[beta] pathway and lymphomagenesis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.